Davita
DaVita Inc. is an American healthcare services company that provides kidney dialysis services and specialized medical care for patients suffering from chronic kidney failure. The company operates through distinct business segments focused on U.S. dialysis services, international operations, and integrated kidney care programs. Its primary service offerings include outpatient hemodialysis, peritoneal dialysis, home dialysis training, inpatient hospital dialysis services, and physician-led clinical care. Principal revenue drivers stem from patient treatment fees billed to government healthcare programs, private health insurers, and managed care organizations. The firm maintains a substantial international scale and a leading market position as one of the largest providers of kidney dialysis services in North America. The company is officially headquartered in Denver, Colorado, in the United States, while its common stock is publicly listed and traded on the New York Stock Exchange.
35 of the funds FundTelligence covers report a position in Davita.
- Legal name
- DAVITA INC
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 35
- Exposure themes
- Ageing & Longevity, Age-Related Disease, Renal Care
Funds holding Davita
- Invesco Social Progress Fund — Invesco · 2.0 % (largest positions only, June 2026)
- Cicero Offensiv Hållbar — Cicero Fonder · 1.93 % (full portfolio disclosed, June 2026)
- Aktiespararna Global Direktavkastning — Cicero Fonder · 1.42 % (full portfolio disclosed, June 2026)
- Pareto ESG Global Corporate Bond — Pareto · 1.33 % (full portfolio disclosed, June 2026)
- Cicero Hållbar Mix — Cicero Fonder · 1.31 % (full portfolio disclosed, June 2026)
- Nordea Global Diversity Engagement Fund — Nordea Funds · 0.67 % (full portfolio disclosed, September 2026)
- Nordea World — Nordea Funds · 0.59 % (full portfolio disclosed, September 2026)
- Mercer Global High Yield Bond Fund — Mercer · 0.45 % (full portfolio disclosed, December 2025)
Showing the 8 largest of 35 funds holding it.